Edit |   |
---|---|
Antigenic Specificity | ERBB3, Human (Duligotuzumab biosimilar) |
Clone | Duligotuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS, IF, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ERBB3 Recombinant Antibody (Duligotuzumab). Duligotuzumab (INN) is a humanized IgG1 monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER3. It is in development by Roche. Clinical development for head and neck cancer and colorectal cancer have been discontinued, but phase I trials in combination with cobimetinib are evaluating safety for treatment of solid tumors. |
Immunogen | n/a |
Other Names | Anti-ERBB3 Recombinant Antibody, Research Grade Duligotuzumab, Anti-Human ERBB3 Recombinant Antibody(Duligotuzumab), MEHD7945A, RG-7597, Antibody Drug Analogues, Monoclonal Antibody, YR1277, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1314238-96-4 |
Catalog # | YR1277 |
Price | please inquire |
Order / More Info | ERBB3, Human (Duligotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |